Pharmaceutical nanosuspension
US10251866B2 · kind B2 · utility
0Cited by
2References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 18, 2012 |
| Grant date | Apr 9, 2019 |
| Priority date | — |
| Expiry date | Jul 1, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P33/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention in general relates to a pharmaceutical suspension comprising nano-sized cocrystals of at least one active ingredient and at least one dicarboxylic acid. It in particular relates to a pharmaceutical suspension comprising nano-sized cocrystals of at least one anthelmintic drug and at least one dicarboxylic acid. The invention further relates to uses, methods for use and methods for manufacturing the pharmaceutical suspension according to this invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.